Specialized Medical Company: FY 2025 saw record revenue, strong profit growth, and major expansion in acute and outpatient care

About this update from Specialized Medical Company

Record FY 2025 results with 7% revenue growth and 43.7% higher net profit, driven by a shift to acute and outpatient services. Board recommended 80 million ordinary and 200 million special dividends, with major expansion projects underway.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Specialized Medical Company